Shailendra is active in AIChE’s Pharma community, as well as in academic and industrial consortia. He served on the leadership team of the AIChE Pharmaceutical Discovery, Development, and Manufacturing (PD2M) Forum and was the Forum program chair for the 2014 AIChE Annual Meeting. He also served on the Board of Directors of the Enabling Technologies Consortium and the IQ Consortium to advance science, technology, and regulatory thinking through pre-competitive collaborations aimed at transformational solutions that benefit patients and the broader pharmaceutical community.
